Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety [PDF]
Patient Safety in Surgery, 2008 Incremental doses of intravenous labetalol are safe and effective and, at times, such therapy may need to be augmented by a continuous infusion of labetalol to control severe hypertension.
Papadimos Thomas J +2 more
doaj +3 more sources
Executive Summary of the 2024 Philippine Clinical Practice Guidelines on the Diagnosis and Management of Acute Severe Blood Pressure Elevation. [PDF]
J Clin Hypertens (Greenwich)ABSTRACT A recent survey in the Philippines, PRESYON‐4, showed increasing prevalence of hypertension from 22% in the 1990s to 37% in 2021, of which only 52% were aware of their diagnosis. While rates of treatment and adherence were 68% and 86%, respectively, the rate of BP control was low at 37%. Furthermore, there remained a high degree of unawareness
Ona DID +17 more
europepmc +2 more sources
Effect of labetalol for treating patients with pregnancy-induced hypertension: A systematic review
Journal of the Practice of Cardiovascular Sciences, 2022 Pregnancy-induced hypertension (PIH) is one of the main causes of maternal mortality. Many first- and second-line drugs are available to treat the condition. Labetalol lowers blood pressure by blocking both α and β adrenergic receptors.
Punyatoya Bej, Sambhunath Das
doaj +1 more source
Acta Medica Iranica, 2020 The bleeding during dacryocystorhinostomy (DCR) surgery is one of the main complications that led to the surgeon’s dissatisfaction and increased the duration of the operation.
Mehdi Sanatkar +2 more
doaj +1 more source
Cardiac dysfunction during adverse maternal outcomes in hypertensive disorders of pregnancy. [PDF]
Acta Obstet Gynecol ScandIn pregnancies complicated by hypertensive disorders, peripartum adverse maternal outcomes are associated with diastolic cardiac dysfunction. Elevated E/e' ratio and left atrial volume index highlight the need for targeted cardiovascular monitoring and long‐term follow‐up.
Giorgione V +5 more
europepmc +2 more sources
Retrospective evaluation of labetalol as antihypertensive agent in dogs
BMC Veterinary Research, 2020 Background To evaluate the effect on arterial blood pressure (ABP) of labetalol infusion as treatment for perioperative non nociceptive acute hypertension in dogs.
Francesco Zublena +2 more
doaj +1 more source
Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans : lost in translation [PDF]
, 2013 We greatly appreciate the comments offered by Drs Rolle, Takematsu, and Hoffman and the opportunity to put our work into a wider perspective. We share the view that our work does not reflect the clinical situation but rather provides a proof of mechanism
Boehrer +26 more
core +1 more source
Determination of potential genotoxic impurities in labetalol hydrochloride by HPLC-MS/MS method [PDF]
Journal of Hebei University of Science and TechnologyIn order to better control the potential genotoxic impurities in labetalol hydrochloride and ensure the safety of medication, a high-performance liquid chromatography-mass spectrometry(HPLC-MS/MS) method was established to detect potential genotoxic ...
Jiarui HAN +3 more
doaj +1 more source
Management of a pregnant woman with fibromuscular dysplasia [PDF]
, 2018 No abstract ...
Berra, Elena +10 more
core +1 more source
How to assess and manage hypertension during and after pregnancy. [PDF]
, 2013 Hypertensive disorders of pregnancy are increasingly important complications of which clinicians should have an up-to-date knowledge to facilitate prompt recognition, diagnosis and management.
Freeman, Dilys +3 more
core +1 more source